Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Dooms

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Contact Dermatitis|June 4, 2009
Allergic contact dermatitis from fragrance components in specific topical pharmaceutical products in BelgiumAndrea Nardelli, Ellen D'Hooghe, Jacques Drieghe, et al.
Journal of Medical Ethics|September 28, 2011
A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug RegulationWim Pinxten, Yvonne Denier, Marc Dooms, et al.
Orphanet Journal of Rare Diseases|May 6, 2019
Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in BelgiumLiese Vandeborne, Eline van Overbeeke, Marc Dooms, et al.
European Journal of Medical Genetics|October 7, 2024
Lessons learned from the RE(ACT) conference on medical devices for rare diseasesAnneliene H Jonker, Tim Buckinx, Lucia Pannese, et al.
Frontiers in Pediatrics|September 20, 2021
Clinical Research in Neonates: Redesigning the Informed Consent Process in the Digital EraEvelien De Sutter, Birte Coopmans, Femke Vanendert, et al.
Personalized Medicine|May 2, 2018
Noninvasive prenatal testing: a survey of young (future) parents in FlandersPascal Borry, Maddalena Favaretto, Ann Batthyany, et al.
Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.
Frontiers in Pharmacology|December 13, 2019
Reimbursement Status and Recommendations Related to Orphan Drugs in European CountriesEwa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, et al.
EMBO Molecular Medicine|June 27, 2023
Targeting shared molecular etiologies to accelerate drug development for rare diseasesGalliano Zanello, Macarena Garrido-Estepa, Ana Crespo, et al.
Frontiers in Pharmacology|December 4, 2024
Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countriesSzczepan Jakubowski, Przemysław Holko, Rafał Nowak, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Contact Dermatitis|June 4, 2009
Allergic contact dermatitis from fragrance components in specific topical pharmaceutical products in BelgiumAndrea Nardelli, Ellen D'Hooghe, Jacques Drieghe, et al.
Journal of Medical Ethics|September 28, 2011
A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug RegulationWim Pinxten, Yvonne Denier, Marc Dooms, et al.
Orphanet Journal of Rare Diseases|May 6, 2019
Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in BelgiumLiese Vandeborne, Eline van Overbeeke, Marc Dooms, et al.
European Journal of Medical Genetics|October 7, 2024
Lessons learned from the RE(ACT) conference on medical devices for rare diseasesAnneliene H Jonker, Tim Buckinx, Lucia Pannese, et al.
Frontiers in Pediatrics|September 20, 2021
Clinical Research in Neonates: Redesigning the Informed Consent Process in the Digital EraEvelien De Sutter, Birte Coopmans, Femke Vanendert, et al.
Personalized Medicine|May 2, 2018
Noninvasive prenatal testing: a survey of young (future) parents in FlandersPascal Borry, Maddalena Favaretto, Ann Batthyany, et al.
Frontiers in Medicine|October 27, 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and PracticeRosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, et al.
Frontiers in Pharmacology|December 13, 2019
Reimbursement Status and Recommendations Related to Orphan Drugs in European CountriesEwa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, et al.
EMBO Molecular Medicine|June 27, 2023
Targeting shared molecular etiologies to accelerate drug development for rare diseasesGalliano Zanello, Macarena Garrido-Estepa, Ana Crespo, et al.
Frontiers in Pharmacology|December 4, 2024
Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countriesSzczepan Jakubowski, Przemysław Holko, Rafał Nowak, et al.
Pageof 3